Stocks
Regencell Bioscience Holdings LimitedRGC
NASDAQHealthcareBiotechnology$23.23-3.21%
Focused on developing treatments based on traditional Chinese medicine, the company is pursuing therapies for neurocognitive and behavioral disorders such as ADHD and autism spectrum disorder. The Hong Kong–based firm is listed on Nasdaq and remains a clinical‑stage biotechnology developer with limi...
Market Cap: $11.5B52W Range: $0.33 – $83.60
Congressional Interest in Regencell Bioscience Holdings Limited (RGC)
7 members of Congress have disclosed 18 trades in Regencell Bioscience Holdings Limited (RGC), a Healthcare company. The buy/sell breakdown shows 5 purchases versus 13 sales, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
18
Unique Politicians
7
Buys
5
Sells
13
Who in Congress Is Trading RGC?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2018-01-09 | Lois Frankel | sell | $1K – $15K |
| 2018-01-08 | Lois Frankel | sell | $1K – $15K |